1 / 10

PharmD-MD Collaborative

Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) RCI Demonstration Project Jan Hirsch, PhD Right Care Leadership Summit - 10/01/2010. R. R. PharmD-MD Collaborative. Usual Care. Internal Medicine Group – UCSD

amie
Download Presentation

PharmD-MD Collaborative

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) RCI Demonstration ProjectJan Hirsch, PhDRight Care Leadership Summit - 10/01/2010

  2. R R PharmD-MD Collaborative Usual Care • Internal Medicine Group – UCSD • Registry to identify HTN patients “not at goal” (n=90 per group) • >140/90 (or >130/80 with diabetes) • PharmD two ½ day sessions per week • Collaborative Practice Protocol • MTMS activities: • drug therapy initiation and monitoring • medication dosage adjustments • physical assessment (BP, height, weight) • laboratory test review/order • patient education • Clinic visits and follow-up phone calls

  3. Specific Aims • Compare change in systolic and diastolic blood pressure between groups at 6 and 9 months. • Evaluate MTMS model • number and type of medication changes • number and type of drug therapy problems identified and resolved • patient satisfaction • medication and medical resource utilization • return on investment (ROI) • Explore possible markers to target patients most likely to have high benefit vs. cost ratio for future pharmacist MTMS. • Interpret clinical, economic and humanistic outcomes from 3 stakeholder perspectives (Medical Group, Health Plan, Patient). • Stakeholder Interpretation Group

  4. Timeline As of 9-29-10 1/2011 1st Patient 6 mos. Enrolled: 40 Initial Visit: 34 22 initial visit only 8 initial visit + 1 follow-up 4 initial visit + 2 follow-up 7/2010 8/2011 9/2011 1st Patient In Last Patient 9 mos. Chart Review Usual Care Patients

  5. Patient Descriptors (n=31) 1 George J et al., Ann Pharmacother: 2004;38:1369-76.

  6. Patient Descriptors (n=31) 2 Morisky Scale

  7. Actions (n=31)

  8. Questions?

  9. BACKUP SLIDES

  10. Patients Inclusion criteria: Age 18 or over • Diagnosis of hypertension with most recent BP>140/90 mmHg (ICD9code 401.xx) or BP>130/80 mmHg if patient also has diabetes • Currently treated with at least one anti-hypertensive medication • Continuous active patient of the clinic for at least the past 6 months • English speaking and able to complete questionnaires in English

More Related